AbstractAbstract
[en] Medical intervention should begin within a few hours after contamination of the human body, otherwise it is impossible to influence the deposition of radioisotopes in the organs and tissues. The choice of decorporating drugs is very limited. One of them is DTPA, capable to accelerate the discharge of transition, rare earth and transuranic elements from the body. Various new agents have been developed for this purpose which can bind radioactive strontium in body fluids and tissues. These new pharmaceuticals are reported preliminarily, and the first experimental results are presented. (N.T.)
Primary Subject
Source
Uri, G. (ed.); [395 p.]; ISBN 963 04 3860 7; ; 1993; p. 137-140; Hungarian Korean Technical Cooperation Center Foundation; Budapest (Hungary); 3. Hungarian Korean symposium on nuclear energy; Balatonfuered (Hungary); 30 Mar - 2 Apr 1993
Record Type
Book
Literature Type
Conference
Country of publication
Descriptors (DEI)
Descriptors (DEC)
AMINO ACIDS, BETA DECAY RADIOISOTOPES, BETA-MINUS DECAY RADIOISOTOPES, CARBOXYLIC ACIDS, CHELATING AGENTS, CLEANING, DRUGS, EVEN-EVEN NUCLEI, INTERMEDIATE MASS NUCLEI, ISOTOPES, NUCLEI, ORGANIC ACIDS, ORGANIC COMPOUNDS, RADIOISOTOPES, RESPONSE MODIFYING FACTORS, STRONTIUM ISOTOPES, YEARS LIVING RADIOISOTOPES
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue